Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy — U.S. Territories, January 1, 2016–April 25, 2017

Carrie K. Shapiro‐Mendoza(Office of Readiness and Response), Marion E. Rice(Office of Readiness and Response), Romeo R. Galang(Office of Readiness and Response), Anna C. Fulton(Office of Readiness and Response), Kelley VanMaldeghem(Office of Readiness and Response), Miguel Valencia Prado(Office of Readiness and Response), Esther M. Ellis(Office of Readiness and Response), Magele Scott Anesi(Office of Readiness and Response), Regina M. Simeone(Office of Readiness and Response), Emily E. Petersen(Office of Readiness and Response), Sascha Ellington(Office of Readiness and Response), Abbey M. Jones(Office of Readiness and Response), Tonya Williams(Office of Readiness and Response), Sarah Reagan-Steiner(Office of Readiness and Response), Janice Pérez‐Padilla(Office of Readiness and Response), Carmen Deseda(Office of Readiness and Response), Andrew J Beron(Office of Readiness and Response), Aifili Tufa(Office of Readiness and Response), Asher Y. Rosinger(Office of Readiness and Response), Nicole M. Roth(Office of Readiness and Response), Caitlin Green(Office of Readiness and Response), Stacey W. Martin(Office of Readiness and Response), Camille Delgado López(Office of Readiness and Response), Leah DeWilde(Office of Readiness and Response), Mary Goodwin(Office of Readiness and Response), H. Pamela Pagano(Office of Readiness and Response), Cara T. Mai(Office of Readiness and Response), Carolyn Gould(Office of Readiness and Response), Sherif R. Zaki(Office of Readiness and Response), Leishla Nieves Ferrer(Office of Readiness and Response), Michelle Davis(Office of Readiness and Response), Eva Lathrop(Office of Readiness and Response), Kara D. Polen(Office of Readiness and Response), Janet D. Cragan(Office of Readiness and Response), Megan R. Reynolds(Office of Readiness and Response), Kimberly Newsome(Office of Readiness and Response), Mariam Marcano Huertas(Office of Readiness and Response), Julu Bhatangar(Office of Readiness and Response), Alma Martinez Quiñones(Office of Readiness and Response), John F. Nahabedian(Office of Readiness and Response), Laura E. Adams(Office of Readiness and Response), Tyler M. Sharp(Office of Readiness and Response), W. Thane Hancock(Office of Readiness and Response), Sonja A. Rasmussen(Office of Readiness and Response), Cynthia A. Moore(Office of Readiness and Response), Denise J. Jamieson(Office of Readiness and Response), Jorge L. Muñoz‐Jordán(Office of Readiness and Response), Helentina Garstang(Office of Readiness and Response), Afeke Kambui(Office of Readiness and Response), Carolee Masao(Office of Readiness and Response), Margaret A. Honein(Office of Readiness and Response), Dana Meaney‐Delman(Office of Readiness and Response), Zika Pregnancy and Infant Registries Working Group(Office of Readiness and Response), Zika Pregnancy and Infant Registries Working Group, Adriana Rico, Alba Phippard(Office of Readiness and Response), Alexis B. Peterson, Ana Pomales, Annelise C. Arth(Office of Readiness and Response), April L. Dawson, Araceli Rey, Argelia Figueroa, Audilis Sanchez(Office of Readiness and Response), Brittany Robinson, Daniel B. Williams, Deborah L. Dee, D Forbes, Elizabeth C. Ailes, Frances Marrero, Gamola Z. Fortenberry, Hilda Razzaghi, Jean Y. Ko, Jennifer N. Lind, Kenneth L. Dominguez(Office of Readiness and Response), Kristie L. Clarke, Maria Manuel Flores, Matthew Biggerstaff, Melissa L. Danielson, Monica Molina, Nicholas J. Somerville, Rachel Blumenfeld, Raegan A. Tuff(Office of Readiness and Response), Rebecca J. Free(Office of Readiness and Response), Sae‐Rom Chae(Office of Readiness and Response), Sara Andrist(Office of Readiness and Response), Shin Y. Kim, Tanya Williams, Theresa Harrington, Tracy Thomason, Vikram Krishnasamy
MMWR Morbidity and Mortality Weekly Report
June 8, 2017
Cited by 277Open Access
Full Text

Abstract

(4,5). Among completed pregnancies with positive nucleic acid tests confirming Zika infection identified in the first, second, and third trimesters, the percentage of fetuses or infants with possible Zika-associated birth defects was 8%, 5%, and 4%, respectively. Among liveborn infants, 59% had Zika laboratory testing results reported to the pregnancy and infant registries. Identification and follow-up of infants born to women with laboratory evidence of recent possible Zika virus infection during pregnancy permits timely and appropriate clinical intervention services (6).


Related Papers

No related papers found

Powered by citation graph analysis